News & Events :: Alzamend Neuro, Inc. (ALZN)

Recent News View All News

Aug 4, 2021 6:30am EDT

Alzamend Neuro Announces Additional Investment Under Its Investigational New Drug Application for AL001 for Dementia Related to Alzheimer’s Pursuant to the Securities Purchase Agreement with Digital Power Lending

Jul 30, 2021 6:30am EDT

Alzamend Neuro Announces Pre-IND Submission for AL002 as a Cell-Based Therapeutic Vaccine That Seeks to Restore the Ability of Patient’s Immunological System to Combat Alzheimer’s

Recent Events View IR Calendar

Jul 12, 2021 9:30 am EDT

Alzamend to Ring Nasdaq Opening Bell Today

View IR Calendar

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings